NovelStem International Corp. (NSTM)
0.0106
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
NovelStem International Cash from Operations (Annual) : -0.1676M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.1676M |
| December 31, 2024 | -0.272M |
| December 31, 2023 | -0.3483M |
| December 31, 2022 | -0.1823M |
| December 31, 2021 | |
| December 31, 2020 | |
| December 31, 2019 | |
| December 31, 2018 | |
| December 31, 2017 | |
| December 31, 2016 | |
| December 31, 2015 | |
| December 31, 2014 | |
| December 31, 2013 | |
| December 31, 2012 | -3.916M |
| Date | Value |
|---|---|
| December 31, 2011 | -2.595M |
| December 31, 2010 | 3.931M |
| December 31, 2009 | 0.078M |
| December 31, 2008 | -7.177M |
| December 31, 2007 | -7.647M |
| December 31, 2006 | -2.710M |
| December 31, 2005 | -3.830M |
| December 31, 2004 | -5.773M |
| December 31, 2003 | -0.3513M |
| December 31, 2002 | -3.958M |
| December 31, 2001 | -5.414M |
| December 31, 2000 | -13.02M |
| December 31, 1999 | -9.877M |
| December 31, 1998 | -5.606M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Brainstorm Cell Therapeutics, Inc. | -6.975M |
| Summit Therapeutics, Inc. | -322.93M |
| Kezar Life Sciences, Inc. | -51.78M |
| Protara Therapeutics, Inc. | -56.36M |
| Clene, Inc. | -18.55M |